Elanco Animal Health Reports Fourth Quarter and Full Year 2020 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Elanco Animal Health (ELAN) Tops Q4 EPS by 3c, Offers Guidance
February 24, 2021 6:40 AM ESTElanco Animal Health (NYSE: ELAN) reported Q4 EPS of $0.12, $0.03 better than the analyst estimate of $0.09. Revenue for the quarter came in at $1.14 billion versus the consensus estimate of $1.06 billion.
GUIDANCE:
Elanco Animal Health sees Q1 2021 EPS of $0.20-$0.25, versus the... More
